Literature DB >> 10996631

Importance of CD4(+) T helper cell responses in tumor immunity.

F Ossendorp1, R E Toes, R Offringa, S H van der Burg, C J Melief.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10996631     DOI： 10.1016/s0165-2478(00)00252-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


× No keyword cloud information.
  16 in total

1.  Detection of HLA class II-dependent T helper antigen using antigen phage display.

Authors:  R Somasundaram; K Satyamoorthy; L Caputo; H Yssel; D Herlyn
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

2.  Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.

Authors:  Yangbing Zhao; Zhili Zheng; Hung T Khong; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunother       Date:  2006 Jul-Aug       Impact factor: 4.456

3.  Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma.

Authors:  Tao Xu; Zheli Huang; Bojin Su; Sumei Wang; Donghui Wang; Chunhua Wang; Weihong Wei; Jun Jiang; Guoyi Zhang; Huiling Yang; Weihan Hu
Journal:  Med Oncol       Date:  2014-09-03       Impact factor: 3.064

4.  Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.

Authors:  T W H Flinsenberg; L Spel; M Jansen; D Koning; C de Haar; M Plantinga; R Scholman; M M van Loenen; S Nierkens; L Boon; D van Baarle; M H M Heemskerk; J J Boelens; M Boes
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

5.  Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.

Authors:  Yu-Qing Liu; Ronnie-T Poon; Jeremy Hughes; Qin-Yu Li; Wan-Ching Yu; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.

Authors:  O Utermöhlen; C Schulze-Garg; G Warnecke; R Gugel; J Löhler; W Deppert
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.

Authors:  Paulo Cesar Maciag; Matthew M Seavey; Zhen-Kun Pan; Soldano Ferrone; Yvonne Paterson
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

8.  IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion.

Authors:  K L Knutson; M L Disis
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

9.  Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.

Authors:  Saied Mirshahidi; Victor G Kramer; James B Whitney; Sosthène Essono; Sandra Lee; Glenn Dranoff; Karen S Anderson; Ruth M Ruprecht
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

10.  An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.

Authors:  Kimberly R Kalli; Christopher J Krco; Lynn C Hartmann; Karin Goodman; Matthew J Maurer; Chao Yu; Elliot M Johnson; Courtney L Erskine; Mary L Disis; Peter J Wettstein; John D Fikes; Melanie Beebe; Glenn Ishioka; Keith L Knutson
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.